Navigation Links
Daytime impairments in older men with obstructive sleep apnea are related to total sleep time
Date:2/1/2009

Westchester, Ill. A study in the Feb. 1 issue of the journal SLEEP shows that daytime functional impairments in older men with obstructive sleep apnea (OSA) are largely explained by total sleep time rather than OSA severity.

A modest link between OSA severity and daytime sleepiness, measured by the Epworth Sleepiness Scale, was no longer statistically significant after controlling for total sleep time. Neither sleep disturbances, measured by the Pittsburgh Sleep Quality Index, nor sleep-related quality of life, measure by the Functional Outcome of Sleep Questionnaire, were associated with OSA severity; all three measures were modestly associated with total sleep time.

According to lead author Dr. Eric J. Kezirian, director of the division of sleep surgery in the department of otolaryngology at the University of California in San Francisco, the study shows that the functional consequences of OSA in older men may differ from those in younger populations and may need to be measured with instruments designed specifically for the demographic.

"While the disorder is associated with behavioral and health-related effects that improve with treatment in young and middle-aged adults, there is little evidence concerning its adverse consequences or treatment benefits in older adults," said Kezirian. "This study showed that in a community-dwelling group of older men, the severity of OSA was not associated with daytime sleepiness, sleep symptoms, or sleep-related quality of life, after controlling for sleep duration."

Data were collected from 2,849 men with a mean age of 76.4 years. Thirteen percent (365/2849) of participants had an ESS of at least 10, a level commonly considered to be excessive sleepiness. The presence and severity of OSA were measured by in-home polysomnography. Overall the study group demonstrated mild to moderate OSA with an average apnea-hypopnea index (AHI) of 17.0. Forty-three percent had an AHI of 15 or more.

Average total sleep time was measured by actigraphy over multiple nights. Thirty-one percent (889/2849) had a short sleep time of less than 360 minutes per night, and the prevalence of short sleep time increased with AHI. Individuals with higher AHI levels also were slightly older than men with lower AHI levels, and they had a higher body mass index, poorer self-reported health status and a higher Geriatric Depression Scale score.

Keizirian said that having a better understanding of OSA in older adults will help medical professionals treat the condition more effectively.

According to the American Academy of Sleep Medicine, OSA is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing soft tissue in the back of the throat to collapse and block the upper airway. This leads to partial reductions (hypopneas) and complete pauses (apneas) in breathing that can produce abrupt reductions in blood oxygen saturation. Brief arousals from sleep restore normal breathing but can cause a fragmented quality of sleep. Most people with sleep apnea snore loudly and frequently, and they often experience excessive daytime sleepiness.


'/>"/>

Contact: Kelly Wagner
kwagner@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Related medicine news :

1. Benefits of a Lifeclinic LC300 Automated Blood Pressure Monitor Recently Featured on Daytime Medical Talk Show
2. Daytime Sleeping Linked to Poor Recovery in Older Patients
3. Daytime TV Addresses the Onslaught of MRSA Cases in U.S.
4. Nutrition Made Simple: Organizing Wellness for Warmer Days With DayTimers
5. Daytime Dozing Might Raise Stroke Risk
6. A Daytime Nap Can Boost Memory
7. Journal Sleep: Study concludes a daytime nap can benefit a persons memory performance
8. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
9. New tool to assess excessive daytime sleepiness in adolescents published in JCSM
10. Daytime, Nighttime Blood Pressure Both Important
11. Journal SLEEP: disturbed sleep linked to poorer daytime function in older women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology: